1. Home
  2. FURY vs SCLX Comparison

FURY vs SCLX Comparison

Compare FURY & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FURY
  • SCLX
  • Stock Information
  • Founded
  • FURY 2008
  • SCLX 2011
  • Country
  • FURY Canada
  • SCLX United States
  • Employees
  • FURY N/A
  • SCLX N/A
  • Industry
  • FURY Precious Metals
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FURY Basic Materials
  • SCLX Health Care
  • Exchange
  • FURY Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • FURY 60.5M
  • SCLX 51.3M
  • IPO Year
  • FURY N/A
  • SCLX N/A
  • Fundamental
  • Price
  • FURY $0.38
  • SCLX $0.24
  • Analyst Decision
  • FURY Strong Buy
  • SCLX Strong Buy
  • Analyst Count
  • FURY 1
  • SCLX 4
  • Target Price
  • FURY $1.10
  • SCLX $14.00
  • AVG Volume (30 Days)
  • FURY 133.4K
  • SCLX 1.1M
  • Earning Date
  • FURY 05-13-2025
  • SCLX 05-12-2025
  • Dividend Yield
  • FURY N/A
  • SCLX N/A
  • EPS Growth
  • FURY N/A
  • SCLX N/A
  • EPS
  • FURY N/A
  • SCLX N/A
  • Revenue
  • FURY N/A
  • SCLX $56,590,000.00
  • Revenue This Year
  • FURY N/A
  • SCLX $24.19
  • Revenue Next Year
  • FURY N/A
  • SCLX $109.90
  • P/E Ratio
  • FURY N/A
  • SCLX N/A
  • Revenue Growth
  • FURY N/A
  • SCLX 22.02
  • 52 Week Low
  • FURY $0.35
  • SCLX $0.21
  • 52 Week High
  • FURY $0.59
  • SCLX $2.30
  • Technical
  • Relative Strength Index (RSI)
  • FURY 43.28
  • SCLX 32.75
  • Support Level
  • FURY $0.39
  • SCLX $0.22
  • Resistance Level
  • FURY $0.42
  • SCLX $0.29
  • Average True Range (ATR)
  • FURY 0.02
  • SCLX 0.03
  • MACD
  • FURY -0.00
  • SCLX -0.00
  • Stochastic Oscillator
  • FURY 0.00
  • SCLX 13.14

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: